- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
Jim Cramer says do your homework, be informed and don't let the wise guys trip you up with their warnings about 'single-stock risk.'
Concert must submit toxicology data to the FDA before proceeding with Phase 2 trials.
Canaccord is bullish on Edwards Lifescience stock.